Get 40% Off
💰 Buffett reveals a $6.7B stake in Chubb. Copy the full portfolio for FREE with InvestingPro’s Stock Ideas toolCopy Portfolios

Medifast (MED) To Post Q3 Earnings: What's In The Offing?

Published 11/05/2019, 10:28 PM
Updated 07/09/2023, 06:31 AM
MED
-
FL
-
OLLI
-
GO
-

Medifast, Inc. (NYSE:MED) is scheduled to report third-quarter 2019 numbers on Nov 7.

The company’s earnings outperformed the Zacks Consensus Estimate by 5.6%, on average, over the trailing four quarters. In the last reported quarter, it witnessed a positive earnings surprise of 2.3%.

The Zacks Consensus Estimate for third-quarter earnings is pegged at $1.33 per share, suggesting growth of 16.7% from the year-ago quarter’s reported figure. The consensus mark for the same has been unchanged over the past 30 days. The consensus mark for revenues is pegged at $194.4 million, suggesting an increase of 39.6% from the year-ago quarter’s reported figure.

MEDIFAST INC Price and EPS Surprise

Key Factors to Note

Medifast has been witnessing consistent growth in OPTAVIA-branded products. Further, growth in active earning coaches has been aiding the company.

On its last earnings call, management had projected revenues of $190-$195 million for the third quarter, which suggests an increase from $139 million reported in the prior-year quarter.

The company’s pricing actions to improve gross margin are expected to have aided its performance in the third quarter. Management forecasted adjusted earnings of $1.3-$1.35 for the third quarter, which suggests an improvement from $1.14 reported in the year-ago quarter.

Moreover, Medifast’s top line in the third quarter is expected to reflect gains from the introduction of its new mobile platform.

However, increased expenses related to the convention held in July and higher IT spend, owing to the implementation of the ERP process, might get reflected in Medifast’s bottom line in the quarter under review.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Zacks Model

Our proven model doesn’t conclusively predict an earnings beat for Medifast this time around. The combination of a positive Earnings ESP and a Zacks Rank #1 (Strong Buy), 2 (Buy) or 3 (Hold) increases the odds of an earnings beat. But that’s not the case here.

The company carries a Zacks Rank #3 (Hold) and Earnings ESP of 0.00%. You can uncover the best stocks to buy or sell before they’re reported with our Earnings ESP Filter.

Stocks With Favorable Combination

Here are some companies you may want to consider as our model shows that these have the right combination of elements to post an earnings beat:

Foot Locker (NYSE:FL) has an Earnings ESP of +2.80% and a Zacks Rank #2 at present. You can see the complete list of today’s Zacks #1 Rank stocks here.

Grocery Outlet Holding (NASDAQ:GO) currently has an Earnings ESP of +2.70% and a Zacks Rank #2.

Ollie’s Bargain Outlet Holdings (NASDAQ:OLLI) presently has an Earnings ESP of +3.45% and a Zacks Rank #3.

Just Released: Zacks’ 7 Best Stocks for Today

Experts extracted 7 stocks from the list of 220 Zacks Rank #1 Strong Buys that has beaten the market more than 2X over with a stunning average gain of +24.5% per year.

These 7 were selected because of their superior potential for immediate breakout.

See these time-sensitive tickers now >>



Ollie's Bargain Outlet Holdings, Inc. (OLLI): Free Stock Analysis Report

MEDIFAST INC (MED): Free Stock Analysis Report
3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .


Foot Locker, Inc. (FL): Free Stock Analysis Report

Grocery Outlet Holding Corp. (GO): Free Stock Analysis Report

Original post

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.